These results replicate findings from the earlier COVID-OUT randomized trial, supporting metformin as an accessible, safe, and inexpensive tool to lower long-term complications after an acute infection.
academic.oup.com/cid/advance-...
Treating acute COVID-19 with 14 days of metformin has a 63–98% probability of cutting the risk in half of having any symptoms, more severe symptoms, or a c
